Snibe

Snibe Shenzhen New Industries Biomedical Engineering Co., Ltd. (Snibe) is a bio-medical company specialize Snibe's striving for excellence never ends.

(Snibe) is located in National Biological Industry Park, Shenzhen, China. Since 1995, Snibe has focused on IVD field for 30 years and also become the first chemiluminescence immunoassay manufacturer who got FDA cleared in China. With four core R&D centers, including reagent, instrument, magnetic microbead, and reagent raw material, Snibe develops a wide range of CLIA test menus. Now, Snibe's produ

cts have spread to 161 countries globally with installations of about 40,000 units. To be the pioneer in the global diagnosis field is our vision.

28/04/2026

of Customers
With a throughput of 600 tests per hour, the MAGLUMI X8 provides high-performance detection to meet the rising needs of modern laboratories.

Let's hear real experience from our Russian customer, and explore how the fully-auto Chemiluminescence Immunoassay (CLIA) System MAGLUMI X8 helps laboratories lift overall work efficiency to a new level.

We are delighted to announce the signing of a Memorandum of Understanding (MOU) with the Vietnamese Association of Clini...
27/04/2026

We are delighted to announce the signing of a Memorandum of Understanding (MOU) with the Vietnamese Association of Clinical Biochemists (VACB) on April 24, 2026. The signing ceremony was attended by Assoc. Prof. Pham Thien Ngoc, Vice President of VACB, and Ms. Lucy Liu, the Vice President of Snibe. The signing ceremony was witnessed by executive members of VACB and other members of Snibe.

As an authoritative professional organization in Vietnam's medical field, VACB is committed to advancing clinical laboratory services, medical research, and professional training in the country. This strategic partnership reflects our shared vision to deepen cross-border medical cooperation, promote excellence in clinical biochemistry and laboratory medicine, and boost regional healthcare development.

We are extremely honored to share a new paper from Clinical Chemistry and Laboratory Medicine (CCLM) on the Snibe small ...
20/04/2026

We are extremely honored to share a new paper from Clinical Chemistry and Laboratory Medicine (CCLM) on the Snibe small molecule sandwich reagent—the angiotensin I (Ang I) assay.

Ang I can reflects the plasma renin activity (PRA) and functional status of the renin angiotensin aldosterone system (RAAS). In traditional immunoassays, small molecules typically present limited epitope due to their compact size and steric constraints, which has long confined them to competitive detection formats. Unfortunately, this approach comes with inherent trade-offs—particularly limited sensitivity and suboptimal specificity, especially at low concentrations—while also posing challenges for automation.

To address these methodological challenges, Snibe developed a small molecule sandwich chemiluminescence assay. This study suggests that the Snibe MAGLUMI® Ang I sandwich assay exhibits excellent agreement with the LC MS/MS gold standard in both Ang I detection and derived PRA. Even at low PRA levels, the agreement remains outstanding. Please find the link to the original paper below.
https://www.degruyterbrill.com/document/doi/10.1515/cclm-2025-1361/html

16/04/2026

🎬 Lumi Talk | Episode 5: What makes Snibe unique?🌍

New episode out now! 🎙 We're honored to invite Prof. Mario Plebani—Editor in Chief of the Journal CCLM and Diagnosis (Dx), a leading expert in Laboratory Medicine—to share his professional perspectives on Snibe!💬

From Maglumi's immunoassay panel to total automation & quality upgrades—he shares insights on Snibe's uniqueness.

If you had to describe Snibe in one word, what would it be? Let's chat! Tune in now 👇 & join the conversation!

15/04/2026

of Customers

Providing cutting-edge intelligence and compatible design for accurate test results and space effectiveness, MAGLUMI X3 has a lessened size but no less power.

Let's hear the voice of our customers from Belgium about how MAGLUMI X3, the fully automated chemiluminescence immunoassay (CLIA) system, works to maximize lab efficiency and also assist in research and medical evaluation.

We are delighted to announce the signing of a Memorandum of Understanding (MOU) with the University of Ghana Medical Cen...
14/04/2026

We are delighted to announce the signing of a Memorandum of Understanding (MOU) with the University of Ghana Medical Centre Ltd (UGMC) on April 12, 2026. The signing ceremony was attended by Dr. Abdul-Samed Tanko, Chief Executive Officer of UGMC, and Ms. Lucy Liu, the Vice President of Snibe.

As a premier medical institution in Ghana, UGMC is committed to delivering high-quality healthcare, advancing medical research and education, and driving continuous progress in public health across the region. This strategic partnership reflects our shared vision to promote global collaboration and professional excellence in laboratory medicine.

09/04/2026

🚨 Dengue is a widespread mosquito-borne disease transmitted by Aedes mosquitoes, affecting millions globally each year. Check out the animation to learn its spread, common symptoms, and practical protection tips. Swipe to watch and share to raise awareness! 💛

Snibe is committed to safeguarding human health comprehensively and paying close attention to the development of infectious diseases. 💪

When efficiency meets automation — Biossays C10 makes it happen!With 200 reagent positions and 3,000 tests per hour tota...
08/04/2026

When efficiency meets automation — Biossays C10 makes it happen!

With 200 reagent positions and 3,000 tests per hour total throughput, it will never trouble you to run biochemistry and ISE testing simultaneously at high speed.

C10 also supports whole blood HbA1c testing, which means no lengthy sample pretreatment and saving more time without manual operation!

From reducing the sample processing to boosting overall efficiency, the Biossays C10 empowers your lab to handle growing demands without compromise.

Ready to upgrade your lab's performance now?
👉https://www.snibe.com/en/product/biochemistry_analyzer/652.html

02/04/2026

🎬 Lumi Talk | Episode 4: Working at Snibe🌍

New episode out now! 🎙 We invited our international training specialist Fady Farouk to share what it's really like to work at Snibe.

From first impressions to daily moments that make him feel at home—this one's full of honest stories and good vibes.

How about your work life? Share in the comments!

Tune in now 👉🔗https://youtu.be/1CZc9MElkT8

April is STI Awareness Month, observed to raise public awareness of sexually transmitted infections (STIs).Worldwide, ap...
01/04/2026

April is STI Awareness Month, observed to raise public awareness of sexually transmitted infections (STIs).

Worldwide, approximately one million new curable STIs are reported each day. Getting tested for STIs and staying sexually healthy is increasingly important. This month, we invite you to explore Snibe's reliable and comprehensive testing solutions that help you take charge of your health with confidence: https://www.snibe.com/en/product/CLIA_menu/

Let's make self-care a priority. You deserve to feel safe and empowered!

As chronic liver diseases (CLD) are common global health issue, novel circulating markers for the non-invasive staging o...
31/03/2026

As chronic liver diseases (CLD) are common global health issue, novel circulating markers for the non-invasive staging of the diseases are in high demand. Snibe MAGLUMI provides a broad parameters of HA, LN, PIIIP N-P, C-IV, CG and GP73, which are related to hepatic fibrosis. We are also happy to share a high-quality research conducted by teams from Italy. This study underscores the potential of these extracellular matrix in non-invasive staging CLD. Combined with AI, machine learning could further enhance diagnositc accuracy and reduce the need for invasive biopsies.

Please find the link to the original paper:
https://www.sciencedirect.com/science/article/pii/S0009912024001553

Fibrosis learning

Address

Shenzhen

Opening Hours

Monday 08:30 - 18:00
Tuesday 08:30 - 18:00
Wednesday 08:30 - 18:00
Thursday 08:30 - 18:00
Friday 08:30 - 18:00

Telephone

+8675528292700

Website

Alerts

Be the first to know and let us send you an email when Snibe posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Snibe:

Shortcuts

Share

Category